Selected research
Industry Research
Custom DNA Oligos Industry Research Report 2026
Market perspective
The global Custom DNA Oligos market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Custom DNA Oligos market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Custom DNA Oligos market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Custom DNA Oligos market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Custom DNA Oligos include Wuhan GeneCreate Biological Engineering, General Biol, Atantares, Beyotime, Thermo Fisher Scientific, Merck, Genscript, Guangzhou RiboBio and Tsingke, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Custom DNA Oligos market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Custom DNA Oligos.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Custom DNA Oligos Market by Company
Wuhan GeneCreate Biological Engineering
General Biol
Atantares
Beyotime
Thermo Fisher Scientific
Merck
Genscript
Guangzhou RiboBio
Tsingke
Abace Biotechnology
TriLink BioTechnologies
Synbio Technologies
Macrogen
Integrated DNA Technologies (IDT)
Eurogentec
Cusabio
BBI Life Sciences
Azenta Life Sciences
Aurigene Pharmaceutical Services
Custom DNA Oligos Segment by Type
Common Primer Synthesis
Modified Primer Synthesis
Custom DNA Oligos Segment by Application
Biotech Company
Academic Scientific Research Institution
Custom DNA Oligos Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom DNA Oligos market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom DNA Oligos and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom DNA Oligos.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Custom DNA Oligos companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Common Primer Synthesis
- Modified Primer Synthesis
Applications
- Biotech Company
- Academic Scientific Research Institution
Companies covered
- Wuhan GeneCreate Biological Engineering
- General Biol
- Atantares
- Beyotime
- Thermo Fisher Scientific
- Merck
- Genscript
- Guangzhou RiboBio
- Tsingke
- Abace Biotechnology
- TriLink BioTechnologies
- Synbio Technologies
- Macrogen
- Integrated DNA Technologies (IDT)
- Eurogentec
- Cusabio
- BBI Life Sciences
- Azenta Life Sciences
- Aurigene Pharmaceutical Services
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Custom DNA Oligos by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Common Primer Synthesis
- 2.2.3 Modified Primer Synthesis
- 2.3 Custom DNA Oligos by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biotech Company
- 2.3.3 Academic Scientific Research Institution
- 2.4 Assumptions and Limitations
3 Custom DNA Oligos Breakdown Data by Type
- 3.1 Global Custom DNA Oligos Historic Market Size by Type (2021-2026)
- 3.2 Global Custom DNA Oligos Forecasted Market Size by Type (2027-2032)
4 Custom DNA Oligos Breakdown Data by Application
- 4.1 Global Custom DNA Oligos Historic Market Size by Application (2021-2026)
- 4.2 Global Custom DNA Oligos Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Custom DNA Oligos Market Perspective (2021-2032)
- 5.2 Global Custom DNA Oligos Growth Trends by Region
- 5.2.1 Global Custom DNA Oligos Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Custom DNA Oligos Historic Market Size by Region (2021-2026)
- 5.2.3 Custom DNA Oligos Forecasted Market Size by Region (2027-2032)
- 5.3 Custom DNA Oligos Market Dynamics
- 5.3.1 Custom DNA Oligos Industry Trends
- 5.3.2 Custom DNA Oligos Market Drivers
- 5.3.3 Custom DNA Oligos Market Challenges
- 5.3.4 Custom DNA Oligos Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Custom DNA Oligos Players by Revenue
- 6.1.1 Global Top Custom DNA Oligos Players by Revenue (2021-2026)
- 6.1.2 Global Custom DNA Oligos Revenue Market Share by Players (2021-2026)
- 6.2 Global Custom DNA Oligos Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Custom DNA Oligos Head Office and Area Served
- 6.4 Global Custom DNA Oligos Players, Product Type & Application
- 6.5 Global Custom DNA Oligos Manufacturers Established Date
- 6.6 Global Custom DNA Oligos Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Custom DNA Oligos Market Size (2021-2032)
- 7.2 North America Custom DNA Oligos Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Custom DNA Oligos Market Size by Country (2021-2026)
- 7.4 North America Custom DNA Oligos Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Custom DNA Oligos Market Size (2021-2032)
- 8.2 Europe Custom DNA Oligos Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Custom DNA Oligos Market Size by Country (2021-2026)
- 8.4 Europe Custom DNA Oligos Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Custom DNA Oligos Market Size (2021-2032)
- 9.2 Asia-Pacific Custom DNA Oligos Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Custom DNA Oligos Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Custom DNA Oligos Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Custom DNA Oligos Market Size (2021-2032)
- 10.2 South America Custom DNA Oligos Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Custom DNA Oligos Market Size by Country (2021-2026)
- 10.4 South America Custom DNA Oligos Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Custom DNA Oligos Market Size (2021-2032)
- 11.2 Middle East & Africa Custom DNA Oligos Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Custom DNA Oligos Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Custom DNA Oligos Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Wuhan GeneCreate Biological Engineering
- 12.1.1 Wuhan GeneCreate Biological Engineering Company Information
- 12.1.2 Wuhan GeneCreate Biological Engineering Business Overview
- 12.1.3 Wuhan GeneCreate Biological Engineering Revenue in Custom DNA Oligos Business (2021-2026)
- 12.1.4 Wuhan GeneCreate Biological Engineering Custom DNA Oligos Product Portfolio
- 12.1.5 Wuhan GeneCreate Biological Engineering Recent Developments
- 12.2 General Biol
- 12.2.1 General Biol Company Information
- 12.2.2 General Biol Business Overview
- 12.2.3 General Biol Revenue in Custom DNA Oligos Business (2021-2026)
- 12.2.4 General Biol Custom DNA Oligos Product Portfolio
- 12.2.5 General Biol Recent Developments
- 12.3 Atantares
- 12.3.1 Atantares Company Information
- 12.3.2 Atantares Business Overview
- 12.3.3 Atantares Revenue in Custom DNA Oligos Business (2021-2026)
- 12.3.4 Atantares Custom DNA Oligos Product Portfolio
- 12.3.5 Atantares Recent Developments
- 12.4 Beyotime
- 12.4.1 Beyotime Company Information
- 12.4.2 Beyotime Business Overview
- 12.4.3 Beyotime Revenue in Custom DNA Oligos Business (2021-2026)
- 12.4.4 Beyotime Custom DNA Oligos Product Portfolio
- 12.4.5 Beyotime Recent Developments
- 12.5 Thermo Fisher Scientific
- 12.5.1 Thermo Fisher Scientific Company Information
- 12.5.2 Thermo Fisher Scientific Business Overview
- 12.5.3 Thermo Fisher Scientific Revenue in Custom DNA Oligos Business (2021-2026)
- 12.5.4 Thermo Fisher Scientific Custom DNA Oligos Product Portfolio
- 12.5.5 Thermo Fisher Scientific Recent Developments
- 12.6 Merck
- 12.6.1 Merck Company Information
- 12.6.2 Merck Business Overview
- 12.6.3 Merck Revenue in Custom DNA Oligos Business (2021-2026)
- 12.6.4 Merck Custom DNA Oligos Product Portfolio
- 12.6.5 Merck Recent Developments
- 12.7 Genscript
- 12.7.1 Genscript Company Information
- 12.7.2 Genscript Business Overview
- 12.7.3 Genscript Revenue in Custom DNA Oligos Business (2021-2026)
- 12.7.4 Genscript Custom DNA Oligos Product Portfolio
- 12.7.5 Genscript Recent Developments
- 12.8 Guangzhou RiboBio
- 12.8.1 Guangzhou RiboBio Company Information
- 12.8.2 Guangzhou RiboBio Business Overview
- 12.8.3 Guangzhou RiboBio Revenue in Custom DNA Oligos Business (2021-2026)
- 12.8.4 Guangzhou RiboBio Custom DNA Oligos Product Portfolio
- 12.8.5 Guangzhou RiboBio Recent Developments
- 12.9 Tsingke
- 12.9.1 Tsingke Company Information
- 12.9.2 Tsingke Business Overview
- 12.9.3 Tsingke Revenue in Custom DNA Oligos Business (2021-2026)
- 12.9.4 Tsingke Custom DNA Oligos Product Portfolio
- 12.9.5 Tsingke Recent Developments
- 12.10 Abace Biotechnology
- 12.10.1 Abace Biotechnology Company Information
- 12.10.2 Abace Biotechnology Business Overview
- 12.10.3 Abace Biotechnology Revenue in Custom DNA Oligos Business (2021-2026)
- 12.10.4 Abace Biotechnology Custom DNA Oligos Product Portfolio
- 12.10.5 Abace Biotechnology Recent Developments
- 12.11 TriLink BioTechnologies
- 12.11.1 TriLink BioTechnologies Company Information
- 12.11.2 TriLink BioTechnologies Business Overview
- 12.11.3 TriLink BioTechnologies Revenue in Custom DNA Oligos Business (2021-2026)
- 12.11.4 TriLink BioTechnologies Custom DNA Oligos Product Portfolio
- 12.11.5 TriLink BioTechnologies Recent Developments
- 12.12 Synbio Technologies
- 12.12.1 Synbio Technologies Company Information
- 12.12.2 Synbio Technologies Business Overview
- 12.12.3 Synbio Technologies Revenue in Custom DNA Oligos Business (2021-2026)
- 12.12.4 Synbio Technologies Custom DNA Oligos Product Portfolio
- 12.12.5 Synbio Technologies Recent Developments
- 12.13 Macrogen
- 12.13.1 Macrogen Company Information
- 12.13.2 Macrogen Business Overview
- 12.13.3 Macrogen Revenue in Custom DNA Oligos Business (2021-2026)
- 12.13.4 Macrogen Custom DNA Oligos Product Portfolio
- 12.13.5 Macrogen Recent Developments
- 12.14 Integrated DNA Technologies (IDT)
- 12.14.1 Integrated DNA Technologies (IDT) Company Information
- 12.14.2 Integrated DNA Technologies (IDT) Business Overview
- 12.14.3 Integrated DNA Technologies (IDT) Revenue in Custom DNA Oligos Business (2021-2026)
- 12.14.4 Integrated DNA Technologies (IDT) Custom DNA Oligos Product Portfolio
- 12.14.5 Integrated DNA Technologies (IDT) Recent Developments
- 12.15 Eurogentec
- 12.15.1 Eurogentec Company Information
- 12.15.2 Eurogentec Business Overview
- 12.15.3 Eurogentec Revenue in Custom DNA Oligos Business (2021-2026)
- 12.15.4 Eurogentec Custom DNA Oligos Product Portfolio
- 12.15.5 Eurogentec Recent Developments
- 12.16 Cusabio
- 12.16.1 Cusabio Company Information
- 12.16.2 Cusabio Business Overview
- 12.16.3 Cusabio Revenue in Custom DNA Oligos Business (2021-2026)
- 12.16.4 Cusabio Custom DNA Oligos Product Portfolio
- 12.16.5 Cusabio Recent Developments
- 12.17 BBI Life Sciences
- 12.17.1 BBI Life Sciences Company Information
- 12.17.2 BBI Life Sciences Business Overview
- 12.17.3 BBI Life Sciences Revenue in Custom DNA Oligos Business (2021-2026)
- 12.17.4 BBI Life Sciences Custom DNA Oligos Product Portfolio
- 12.17.5 BBI Life Sciences Recent Developments
- 12.18 Azenta Life Sciences
- 12.18.1 Azenta Life Sciences Company Information
- 12.18.2 Azenta Life Sciences Business Overview
- 12.18.3 Azenta Life Sciences Revenue in Custom DNA Oligos Business (2021-2026)
- 12.18.4 Azenta Life Sciences Custom DNA Oligos Product Portfolio
- 12.18.5 Azenta Life Sciences Recent Developments
- 12.19 Aurigene Pharmaceutical Services
- 12.19.1 Aurigene Pharmaceutical Services Company Information
- 12.19.2 Aurigene Pharmaceutical Services Business Overview
- 12.19.3 Aurigene Pharmaceutical Services Revenue in Custom DNA Oligos Business (2021-2026)
- 12.19.4 Aurigene Pharmaceutical Services Custom DNA Oligos Product Portfolio
- 12.19.5 Aurigene Pharmaceutical Services Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst